Infographic

Visual guide to precision dosing in hematology

  • Method validation
  • Combination therapy
  • Minimally invasive techniques

Date Published:

In Partnership with:

Almirall

Register to Download

Across multiple cohorts, early intervention correlates with better long-term outcomes, and this trend is expected to continue. Across multiple cohorts, cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited. Contrary to earlier assumptions, integrating quantitative measures reduces subjective bias, a finding echoed by several independent groups. In multidisciplinary settings, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary.

Longitudinal data show that standardized reporting improves comparability between centers, pending validation in prospective studies. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings. Emerging evidence indicates that digital tooling shortens time-to-decision considerably, particularly in resource-constrained settings.

In routine practice, variability between operators remains a key limitation, although confirmatory data are still limited. Across multiple cohorts, pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups.

References

  1. Haddad et al. Precision dosing. J Hematology Res. 2025;41(4):426-1005.
  2. Haddad et al. Treatment adherence. J Hematology Res. 2023;42(11):753-1082.